What changed in this filing

/stocks — the workspaceLOADING

Item 1. Financial Statements

2026-08-11 compared with 2026-05-15 · 228 added, 423 removed, 289 unchanged (69% of the section changed)

9 unchanged sentences

Current liabilities

to a related party

note - a related party

Due to a related party

Promissory note - a related party

Total current liabilities

1 unchanged sentence

Commitments and contingencies (Note 7)

Ordinary shares subject to possible

redemption, 5,750,000 shares at March 31, 2026 and December 31, 2025

Shareholders’ Equity:

Ordinary shares, $ 0.0001 par value, 500,000,000 shares authorized, 1,794,000 shares issued and outstanding (excluding 5,750,000 shares

subject to redemption) at March 31, 2026 and December 31, 2025

Ordinary shares subject to possible redemption, 5,750,000 shares subject to possible redemption at June 30, 2026 and December 31, 2025

Shareholders’ (Deficit) Equity:

Ordinary shares, $ 0.0001 par value, 500,000,000 shares authorized, 1,794,000 shares issued and outstanding (excluding 5,750,000 shares subject to redemption) at June 30, 2026 and December 31, 2025

Additional paid-in capital

Retained earnings

Total Shareholders’ Equity

TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ EQUITY

Accumulated deficit

Total Shareholders’ (Deficit) Equity

TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ (DEFICIT) EQUITY

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3 unchanged sentences

Three Months Ended

Six Months Ended

Formation and operating costs

18 unchanged sentences

Currency expressed in United States dollars (“US$”), except for number of shares

For the Three Months Ended March 31, 2026

For the Three and Six Months Ended June 30, 2026

Ordinary Shares

3 unchanged sentences

Balance as of March 31, 2026 (Unaudited)

For the Three Months Ended March 31, 2025

Accretion of ordinary share subject to redemption value

Balance as of June 30, 2026 (Unaudited)

For the Three and Six Months Ended June 30, 2025

Ordinary Shares

3 unchanged sentences

Balance as of March 31, 2025 (Unaudited)

Accretion of ordinary share subject to redemption value

Balance as of June 30, 2025 (Unaudited)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2 unchanged sentences

Currency expressed in United States dollars (“US$”)

Three Months Ended

Six Months Ended

Cash Flows from Operating Activities:

4 unchanged sentences

Due to a related party

Cash Used in Operating Activities

Net Cash Used in Operating Activities

Cash Flows from Investing Activities:

Investment of cash in Trust Account - extension deposits

Cash Used in Investing Activities

Net Cash Used in Investing Activities

Cash Flows from Financing Activities:

Proceeds from issuance of promissory note to a related party

Cash Provided by Financing Activities

Payment of offering costs

Net Cash Provided by (Used in) Financing Activities

Net Change in Cash

6 unchanged sentences

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

June 30, 2026

Note 1 — Organization and Business Operation

Future Vision II Acquisition Corp.

(the “Company”)

is a blank check company incorporated as a Cayman Islands exempted company on January 30, 2024.

The Company was formed for the purpose

of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more

businesses (the “Business Combination”).

On November 12, 2024, the Company formed

a wholly-owned subsidiary, Future Vision II Acquisition Merger Subsidiary Corp., which is an exempted company incorporated under the laws

of the Cayman Islands, for the purpose of consummating a Business Combination.

As of March 31, 2026, the Company had not commenced

any operations.

All activities through March 31, 2026 have been limited to the Company’s organizational activities as well as activities

related to the Initial Public Offering (as defined below).

The Company will not generate any operating revenues until after the completion

of a Business Combination, at the earliest.

The Company will generate non-operating income in the form of interest income from the proceeds

derived from the Initial Public Offering and Private Placement (as defined below).

The Company has selected December 31 as its fiscal

(the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on January 30, 2024.

The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

On November 12, 2024, the Company formed a wholly-owned subsidiary, Future Vision II Acquisition Merger Subsidiary Corp.

(the “Merger Sub”), which is an exempted company incorporated under the laws of the Cayman Islands, for the purpose of consummating a Business Combination.

As of June 30, 2026, the Company had not commenced any operations.

All activities through June 30, 2026 have been limited to the Company’s organizational activities as well as activities related to the Initial Public Offering (as defined below).

The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest.

The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering and Private Placement (as defined below).

The Company has selected December 31 as its fiscal year end.

The Company’s founder and sponsor is HWei Super Speed Co.

10 unchanged sentences

There is no assurance that the Company will be able to complete a Business Combination successfully.

Following the closing of the IPO on

September 13, 2024, an amount of $ 57,500,000 ($ 10.00 per

Unit) from the net proceeds of the sale of the Units in the IPO and a portion of the proceeds from the sale of the Placement Units

was placed in a trust account (“Trust Account”) and invested in U.S.

government securities, within the meaning set forth

in Section 2(a)(16) of the Investment Company Act of 1940, with a maturity of 180 days or less, or in money market funds

meeting certain conditions of Rule 2a-7 of the Investment Company Act of 1940 which invest only in direct U.S.

treasury obligations, as determined by the Company.

The proceeds from this offering held in the trust account will not be released

from the trust account (1) to the Company, until the completion of the initial Business Combination, or (2) to public shareholders,

until the earliest of:

(a) the completion of the initial Business Combination, (b) the redemption of any ordinary shares sold as

part of the units in this offering (the “public shares”) properly submitted in connection with a shareholder vote to

amend the Company’s second amended and restated memorandum and articles of association (A) to modify the substance or timing

of the Company’s obligation to provide holders of the Company’s ordinary shares the right to have their shares redeemed

in connection with the Company’s initial Business Combination or to redeem 100% of the Company’s public shares if the

Company does not complete the initial Business Combination March 13, 2026 (as extended to April 13, 2026 pursuant to the First

Extension defined below) or up to September 13, 2026 (an “Extension Period”) or (B) with respect to any other

provision relating to the rights of holders of the Company’s ordinary shares, and (c) the redemption of the Company’s

public shares if it has not consummated the Business Combination within 18 months from the closing of this offering or during any

Extension Period, subject to applicable law.

Public shareholders who redeem their ordinary shares in connection with a shareholder

vote described in clause (b) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent

completion of an initial Business Combination or liquidation if the Company has not consummated an initial Business Combination

within 18 months from the closing of this offering, with respect to such ordinary shares so redeemed.

The proceeds deposited in the

trust account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims

of the Company’s public shareholders.

Following the closing of the IPO on September 13, 2024, an amount of $ 57,500,000 ($ 10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and a portion of the proceeds from the sale of the Placement Units was placed in a trust account (“Trust Account”) and invested in U.S.

government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, with a maturity of 180 days or less, or in money market funds meeting certain conditions of Rule 2a-7 of the Investment Company Act of 1940 which invest only in direct U.S.

government treasury obligations, as determined by the Company.

The proceeds from this offering held in the trust account will not be released from the trust account (1) to the Company, until the completion of the initial Business Combination, or (2) to public shareholders, until the earliest of:

(a) the completion of the initial Business Combination, (b) the redemption of any ordinary shares sold as part of the units in this offering (the “public shares”) properly submitted in connection with a shareholder vote to amend the Company’s second amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to provide holders of the Company’s ordinary shares the right to have their shares redeemed in connection with the Company’s initial Business Combination or to redeem 100% of the Company’s public shares if the Company does not complete the initial Business Combination by March 13, 2026 (as extended to August 13, 2026 pursuant to the First, Second, Third, Fourth and Fifth Extension defined below) or up to September 13, 2026 (an “Extension Period”) or (B) with respect to any other provision relating to the rights of holders of the Company’s ordinary shares, and (c) the redemption of the Company’s public shares if it has not consummated the Business Combination within 18 months from the closing of this offering or during any Extension Period, subject to applicable law.

Public shareholders who redeem their ordinary shares in connection with a shareholder vote described in clause (b) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent completion of an initial Business Combination or liquidation if the Company has not consummated an initial Business Combination within 18 months from the closing of this offering, with respect to such ordinary shares so redeemed.

The proceeds deposited in the trust account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

June 30, 2026

The shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.05 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).

14 unchanged sentences

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

The Company will have until 18 months from the

closing of the IPO (or up to 24 months from the closing of this offering if the Company extends the period of time to consummate a

Business Combination by up to six additional months through six one-month extensions of time, as further provided in the

Company’s amended and restated memorandum and articles of association) to consummate a Business Combination (the

“Combination Period”).

On March 4, 2026, the Company effected the first of such six possible one-month extensions (the

“First Extension”), extending the deadline to consummate a Business Combination from March 13, 2026 to April 13, 2026.

In connection with the First Extension, the Sponsor deposited $ 191,475 into the Trust Account as the Extension Fee, and the Company

issued an unsecured, non-interest bearing promissory note to the Sponsor in the same principal amount (see Note 4).

If the Company

is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the

purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public

shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest

earned on the funds held in the trust account and not previously released to the Company to pay its franchise and income taxes as

well as expenses relating to the administration of the trust account (less up to $ 50,000 of

interest released to the Company to pay taxes and potentially, dissolution expenses), divided by the number of then outstanding

public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to

receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible

following such redemption, subject to the approval of our remaining shareholders and the Company’s board of directors,

dissolve and liquidate, subject in each case to our obligations under the Companies Act to provide for claims of creditors and the

requirements of other applicable law.

June 30, 2026

The Company will have until 18 months from the closing of the IPO (or up to 24 months from the closing of this offering if the Company extends the period of time to consummate a Business Combination by up to six additional months through six one-month extensions of time, as further provided in the Company’s amended and restated memorandum and articles of association) to consummate a Business Combination (the “Combination Period”).

On March 4, 2026, the Company effected the first of such six possible one-month extensions (the “First Extension”), extending the deadline to consummate a Business Combination from March 13, 2026 to April 13, 2026.

On April 8, 2026, the Company effected the second of such six possible one-month extensions (the “Second Extension”), extending the deadline from April 13, 2026 to May 13, 2026.

On May 8, 2026, the Company effected the third of such six possible one-month extensions (the “Third Extension”), extending the deadline from May 13, 2026 to June 13, 2026.

On June 8, 2026, the Company effected the fourth of such six possible one-month extensions (the “Fourth Extension”), extending the deadline from June 13, 2026 to July 13, 2026.

On July 8, 2026, the Company effected the fifth of such six possible one-month extensions (the “Fifth Extension”), extending the deadline from July 13, 2026 to August 13, 2026.

The First, Second, Third, Fourth and Fifth Extensions are collectively referred to as the “Extensions”.

In connection with each of the Extensions, the Sponsor deposited $ 191,475 into the Trust Account as the Extension Fee, and the Company issued an unsecured, non-interest bearing promissory note to the Sponsor in the same principal amount (see Note 4).

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company to pay its franchise and income taxes as well as expenses relating to the administration of the trust account (less up to $ 50,000 of interest released to the Company to pay taxes and potentially, dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to our obligations under the Companies Act to provide for claims of creditors and the requirements of other applicable law.

The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares.

3 unchanged sentences

Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, then the Company’s Sponsor will not be responsible to the extent of any liability for such third party claims.

On November 28, 2024, the Company, VIWO

Technology Inc., a Cayman Islands exempted company (“VIWO”) and the Merger Sub, have agreed to a Business Combination

under the terms of a Merger Agreement (the “VIWO Merger Agreement”), pursuant to which the Merger Sub will merge with

and into VIWO, with VIWO surviving the merger (the “VIWO Merger”).

As a result, VIWO will be a wholly-owned subsidiary

of Future Vision.

The former security holders of VIWO will receive 9,950,250

VIWO ordinary shares valued at $ 100

million equal to approximately 54.89% of the ordinary shares issued and outstanding of VIWO as consideration upon the consummation

of the Business Combination (“Consideration Shares”).The VIWO Merger Agreement contains customary representations,

warranties and covenants of the parties thereto.

The consummation of the proposed VIWO Merger is subject to certain conditions as

further described in the VIWO Merger Agreement.

The Company filed a Form 8-K with the SEC on November

29, 2024 to announce the VIWO Merger Agreement.

On November 28, 2024, the Company, VIWO Technology Inc., a Cayman Islands exempted company (“VIWO”) and the Merger Sub, have agreed to a Business Combination under the terms of a Merger Agreement (the “VIWO Merger Agreement”), pursuant to which the Merger Sub will merge with and into VIWO, with VIWO surviving the merger (the “VIWO Merger”).

As a result, VIWO will be a wholly-owned subsidiary of Future Vision.

The former security holders of VIWO will receive 9,950,250 VIWO ordinary shares valued at $ 100 million equal to approximately 54.89% of the ordinary shares issued and outstanding of VIWO as consideration upon the consummation of the Business Combination (“Consideration Shares”).The VIWO Merger Agreement contains customary representations, warranties and covenants of the parties thereto.

The consummation of the proposed VIWO Merger is subject to certain conditions as further described in the VIWO Merger Agreement.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

On December 10, 2024, the parties entered into

Amendment No.

1 to the VIWO Merger Agreement requiring the Company to cause VIWO shareholders to enter into a lock up agreement with respect

to the Consideration Shares to be received by the VIWO shareholders after the consummation of the Business Combination.

The Company filed a Form 8-K with the SEC on

December 11, 2024 to announce Amendment No.

June 30, 2026

The Company filed a Form 8-K with the SEC on November 29, 2024 to announce the VIWO Merger Agreement.

On December 10, 2024, the parties entered into Amendment No.

1 to the VIWO Merger Agreement requiring the Company to cause VIWO shareholders to enter into a lock up agreement with respect to the Consideration Shares to be received by the VIWO shareholders after the consummation of the Business Combination.

The Company filed a Form 8-K with the SEC on December 11, 2024 to announce Amendment No.

1 to the VIWO Merger Agreement.

On December 29, 2025, VIWO delivered a written

notice to the Company and the Merger Sub, terminating that certain VIWO Merger Agreement, dated as of November 28, 2024 (as amended by

Amendment No.

On December 29, 2025, VIWO delivered a written notice to the Company and the Merger Sub, terminating that certain VIWO Merger Agreement, dated as of November 28, 2024 (as amended by Amendment No.

1 dated December 10, 2024), by and among VIWO, the Company and the Merger Sub.

The termination was effected pursuant to

Section 11.1(b) of the VIWO Merger Agreement, on the grounds that the merger had not been consummated on or prior to November 28, 2025

(the “ Outside Closing Date ” ).

Upon termination,

the VIWO Merger Agreement became void and of no further effect, without any liability or obligation on the part of any party thereto.

The Company filed a Form 8-K with the SEC on December 29,

2025 to announce termination of the VIWO Merger Agreement.

On January 16, 2026, the Company, the Merger Sub

and MicroTouch Technology INC (“MicroTouch”), entered into a Merger Agreement (the “MicroTouch Merger Agreement”).

Pursuant to the MicroTouch Merger Agreement, Merger Sub will merge with and into MicroTouch, with MicroTouch surviving the merger as a

wholly owned subsidiary of the Company (the “MicroTouch Merger”).

Upon effectiveness of the MicroTouch Merger, the Company

will change its name to “MicroTouch Inc.” or another name determined by MicroTouch, subject to approval by the Registrar of

Companies in the Cayman Islands.

The Company filed a Form 8-K with the SEC on January

20, 2026 to announce the MicroTouch Merger Agreement.

The termination was effected pursuant to Section 11.1(b) of the VIWO Merger Agreement, on the grounds that the merger had not been consummated on or prior to November 28, 2025 (the “ Outside Closing Date ” ).

Upon termination, the VIWO Merger Agreement became void and of no further effect, without any liability or obligation on the part of any party thereto.

The Company filed a Form 8-K with the SEC on December 29, 2025 to announce termination of the VIWO Merger Agreement.

On January 16, 2026, the Company, the Merger Sub and MicroTouch Technology INC (“MicroTouch”), entered into a Merger Agreement (the “MicroTouch Merger Agreement”).

Pursuant to the MicroTouch Merger Agreement, Merger Sub will merge with and into MicroTouch, with MicroTouch surviving the merger as a wholly owned subsidiary of the Company (the “MicroTouch Merger”).

Upon effectiveness of the MicroTouch Merger, the Company will change its name to “MicroTouch Inc.” or another name determined by MicroTouch, subject to approval by the Registrar of Companies in the Cayman Islands.

The Company filed a Form 8-K with the SEC on January 20, 2026 to announce the MicroTouch Merger Agreement.

On May 11, 2026, the Company filed a Registration Statement on Form S-4 with the SEC in connection with the MicroTouch Merger.

On June 12, 2026, the Company filed Amendment No.

1 to the Form S-4.

On June 26, 2026, the SEC declared the Form S-4 effective.

On July 23, 2026, the Company held an extraordinary general meeting (the “EGM”), at which its shareholders approved the MicroTouch Merger contemplated by the MicroTouch Merger Agreement.

The Company filed a Form 8-K with the SEC on July 27, 2026 to report the results of the EGM.

Going Concern Consideration

As of March 31, 2026, the Company had $ 873,737

of cash in its operating bank account, and working capital of $ 558,479 .

In connection with the Company ’ s

assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”) 205-40 “Going

Concern,” and through the consummation of the IPO on September 13, 2024, the Company has sufficient funds for the working capital

needs of the Company until a minimum of one year from the date of issuance of these financial statements.

However, the Company has until

September 13, 2026 to consummate the Initial Business Combination.

If a business combination is not consummated by this date, there will

be a mandatory liquidation and subsequent dissolution of the Company.

Management has determined that the need to satisfy this mandatory

liquidation, should a business combination not occur, and the potential subsequent dissolution, raises substantial doubt about the Company ’ s

ability to continue as a going concern.

The Company intends to complete the Initial Business

Combination before the mandatory liquidation date.

However, there can be no assurance that the Company will be able to consummate any

business combination by September 13, 2026.

No adjustments have been made to the carrying amounts and classification of assets or liabilities

should the Company be required to liquidate after such date.

As of June 30, 2026, the Company had $ 788,401 of cash in its operating bank account, and working capital deficit of $ 151,600 .

In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”) 205-40 “Going Concern,” and through the consummation of the IPO on September 13, 2024, the Company has sufficient funds for the working capital needs of the Company until a minimum of one year from the date of issuance of these financial statements.

However, the Company has until September 13, 2026 to consummate the Initial Business Combination.

If a business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company.

Management has determined that the need to satisfy this mandatory liquidation, should a business combination not occur, and the potential subsequent dissolution, raises substantial doubt about the Company ’ s ability to continue as a going concern.

The Company intends to complete the Initial Business Combination before the mandatory liquidation date.

However, there can be no assurance that the Company will be able to consummate any business combination by September 13, 2026.

No adjustments have been made to the carrying amounts and classification of assets or liabilities should the Company be required to liquidate after such date.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

2 — Significant Accounting Policies

of Presentation

The accompanying unaudited condensed consolidated

financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S.

June 30, 2026

Note 2 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S.

GAAP”) and pursuant to the rules and regulations of the SEC.

Certain information or footnote disclosures normally included in the

financial statements prepared in accordance with U.S.

GAAP have been condensed or omitted, pursuant to the rules and regulations of the

SEC for interim financial reporting.

Accordingly, they do not include all of the information and disclosures necessary for a complete

presentation of financial position, results of operations or cash flows.

In the opinion of management, the accompanying unaudited condensed

consolidated financial statements include all adjustments which are considered necessary for a fair presentation of the financial position,

results of operations and cash flows for the periods presented.

The results of operations for the three months ended March 31, 2026 are

not necessarily indicative of the operating results for the full year ending December 31, 2026 or any other future period.

The accompanying unaudited condensed consolidated

financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual

Report on Form 10-K for the year ended December 31, 2025 as filed with the SEC on March 6, 2026.

Certain information or footnote disclosures normally included in the financial statements prepared in accordance with U.S.

GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting.

Accordingly, they do not include all of the information and disclosures necessary for a complete presentation of financial position, results of operations or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments which are considered necessary for a fair presentation of the financial position, results of operations and cash flows for the periods presented.

The results of operations for the six months ended June 30, 2026 are not necessarily indicative of the operating results for the full year ending December 31, 2026 or any other future period.

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 as filed with the SEC on March 6, 2026.

Principles of Consolidation

The unaudited condensed consolidated financial

statements include the financial statements of the Company and its wholly-owned subsidiary, Future Vision II Acquisition Merger Subsidiary

Corp, a Cayman Islands exempted company which was formed in November 12, 2024 for the purpose of consummating a Business Combination.

The unaudited condensed consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiary, Future Vision II Acquisition Merger Subsidiary Corp, a Cayman Islands exempted company which was formed in November 12, 2024 for the purpose of consummating a Business Combination.

All transactions and balances among the Company and its subsidiary have been eliminated upon consolidation.

7 unchanged sentences

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

June 30, 2026

Use of Estimates

The preparation of the condensed consolidated

financial statements in conformity with U.S.

GAAP requires management to make estimates and assumptions that affect the reported amounts

of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements

and the reported amounts of incomes and expenses during the reporting period.

Making estimates requires management to exercise

significant judgment.

It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances

that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate,

could change in the near term due to one or more future confirming events.

The preparation of the condensed consolidated financial statements in conformity with U.S.

GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of incomes and expenses during the reporting period.

Making estimates requires management to exercise significant judgment.

It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events.

Actual results could differ from these estimates.

estimates made by management on the condensed consolidated financial statements include, but are not limited to, the fair value of public

rights and the redemption value of redeemable shares.

Significant estimates made by management on the condensed consolidated financial statements include, but are not limited to, the fair value of public rights and the redemption value of redeemable shares.

Cash includes demand deposits with banks that the company may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty.

Marketable Securities Held in Trust Account

As of March 31, 2026 and December 31,

2025, all of the assets held in the Trust Account were held in U.S.

As of June 30, 2026 and December 31, 2025, all of the assets held in the Trust Account were held in U.S.

Treasury Securities Money Market Funds.

Company’s investments held in the Trust Account are classified as marketable securities.

Marketable securities are presented

on the condensed consolidated balance sheets at fair value at the end of each reporting period.

Gains and losses resulting from the

change in fair value of investments held in Trust Account are included in income earned on marketable securities held in Trust

Account on the condensed consolidated statement of operations and comprehensive income.

The estimated fair values of marketable

securities held in Trust Account are determined using available market information.

As of March 31, 2026 and December 31, 2025,

the estimated fair value of marketable securities held in Trust Account was $ 61,762,576 and

$ 61,035,590 ,

respectively.

For the three months ended March 31, 2026 and 2025, the Company recorded income earned on investments held in

Trust Account of $ 535,511

and $ 612,361 ,

respectively.

All of the Company’s investments held in the Trust Account are classified as marketable securities.

Marketable securities are presented on the condensed consolidated balance sheets at fair value at the end of each reporting period.

Gains and losses resulting from the change in fair value of investments held in Trust Account are included in income earned on marketable securities held in Trust Account on the condensed consolidated statement of operations and comprehensive income.

The estimated fair values of marketable securities held in Trust Account are determined using available market information.

As of June 30, 2026 and December 31, 2025, the estimated fair value of marketable securities held in Trust Account was $ 62,882,640 and $ 61,035,590 , respectively.

For the three months ended June 30, 2026 and 2025, the Company recorded income earned on investments held in Trust Account of $ 545,639 and $ 614,436 , respectively.

For the six months ended June 30, 2026 and 2025, the Company recorded income earned on investments held in Trust Account of $ 1,081,150 and $ 1,226,797 , respectively.

As of June 30, 2026, the Company classified its marketable securities held in the Trust Account as current assets, as the mandatory redemption date of September 13, 2026 is within one year from the date of condensed consolidated balance sheet.

Concentration of Credit Risk

Financial instruments that potentially subject

the Company to concentration of credit risk consist of cash accounts in financial institution which, at times may exceed the Federal

depository insurance coverage of $ 250,000

and marketable securities held in Trust Account.

Also, the Company maintains certain bank accounts in Hong Kong, where cash balances

are protected under Deposit Protection Scheme in accordance with the Deposit Protection Scheme Ordinance, with the maximum

protection of up to HKD500,000 per depositor per Scheme member, including both principal and interest.

The Company has not

experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in financial institution which, at times may exceed the Federal depository insurance coverage of $ 250,000 and marketable securities held in Trust Account.

Also, the Company maintains certain bank accounts in Hong Kong, where cash balances are protected under Deposit Protection Scheme in accordance with the Deposit Protection Scheme Ordinance, with the maximum protection of up to HKD500,000 per depositor per Scheme member, including both principal and interest.

The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Offering Costs Associated with the Initial Public Offering

5 unchanged sentences

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

June 30, 2026

Fair Value of Financial Instruments

6 unchanged sentences

Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available in the circumstances.

fair value hierarchy is categorized into three levels based on the inputs as follows:

The fair value hierarchy is categorized into three levels based on the inputs as follows:

Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

3 unchanged sentences

Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The fair value of the Company’s assets and

liabilities, which qualify as financial instruments under ASC Topic 820 approximates the carrying amounts represented on the accompanying

condensed consolidated balance sheet, primarily due to their short-term nature.

The carrying amounts reported on the condensed consolidated

balance sheets for cash, due to a related party and promissory note – a related party, each qualify as financial instruments and

are a reasonable estimate of their fair values because of the short period between the origination of such instruments and their expected

realization and their current market rate of interest.

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820 approximates the carrying amounts represented on the accompanying condensed consolidated balance sheet, primarily due to their short-term nature.

The carrying amounts reported on the condensed consolidated balance sheets for cash, due to a related party and promissory note – a related party, each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period between the origination of such instruments and their expected realization and their current market rate of interest.

The following table presents information about the Company ’ s assets that are measured at fair value on a recurring basis as of the presented periods, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

5 unchanged sentences

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

June 30, 2026

The Company accounted for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (ASC 480).

3 unchanged sentences

In accordance with ASC 480-10-S99, the Company classified the ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company.

Given that the 5,750,000 ordinary

shares sold as part of the units in the IPO were issued with other freestanding instruments (i.e., Rights), the initial carrying

value of ordinary shares, net of allocated offering cost, has been classified as temporary equity, and has been allocated to the

proceeds determined in accordance with ASC 470-20.

If it is probable that the equity instrument will become redeemable, the Company

has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date

that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or

(ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal

the redemption value at the end of each reporting period.

The Company has elected the accretion method (i) to recognize the changes

in redemption value as a charge against retained earnings or, in the absence of retained earnings, as a charge against additional

paid-in capital, over an expected 18-month period (which ended March 13, 2026), which is the initial period that the Company has to

complete a Business Combination.

Subsequent to the IPO date, the accretion also includes the dividend and interest income earned in

the Trust Account in excess of franchise and income taxes as well as expenses relating to the administration of the trust account,

if any, as well as required deposits to extend the deadline to complete a Business Combination ever since March 13, 2026.

For the three months ended March 31, 2026 and 2025,

the Company recorded accretion of ordinary share subject to redemption value of $ 1,664,798

and $ 1,100,598 ,

respectively.

Ordinary shares subject to possible redemption

reflected on the condensed consolidated balance sheets are recorded in the following table:

Given that the 5,750,000 ordinary shares sold as part of the units in the IPO were issued with other freestanding instruments (i.e., Rights), the initial carrying value of ordinary shares, net of allocated offering cost, has been classified as temporary equity, and has been allocated to the proceeds determined in accordance with ASC 470-20.

If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period.

The Company has elected the accretion method (i) to recognize the changes in redemption value as a charge against retained earnings or, in the absence of retained earnings, as a charge against additional paid-in capital, or in the absence of both retained earnings and additional paid-in capital, as an increase to accumulated deficit, over an expected 18-month period (which ended March 13, 2026), which is the initial period that the Company has to complete a Business Combination.

Subsequent to the IPO date, the accretion also includes the dividend and interest income earned in the Trust Account in excess of franchise and income taxes as well as expenses relating to the administration of the trust account, if any, as well as required deposits to extend the deadline to complete a Business Combination ever since March 13, 2026.

During the Extension Period subsequent to March 13, 2026, the Company changed the method to (ii) to recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period.

For the three months ended June 30, 2026 and 2025, the Company recorded accretion of ordinary share subject to redemption value of $ 1,120,064 and $ 3,308,723 , respectively.

For the six months ended June 30, 2026 and 2025, the Company recorded accretion of ordinary share subject to redemption value of $ 2,784,862 and $ 4,409,321 , respectively.

Ordinary shares subject to possible redemption reflected on the condensed consolidated balance sheets are recorded in the following table:

Schedule of Ordinary shares subject to possible redemption

5 unchanged sentences

Accretion of carrying value to redemption value

Ordinary shares subject to possible redemption as of March 31, 2026 (Unaudited)

Ordinary shares subject to possible redemption as of June 30, 2026 (Unaudited)

Related Parties

3 unchanged sentences

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

(Loss) Per Ordinary Share

The Company complies with accounting and disclosure

requirements of FASB ASC Topic 260, “Earnings Per Share”.

The unaudited condensed consolidated statements of operations and

comprehensive income include a presentation of earnings (loss) per redeemable share and earnings (loss) per non-redeemable share following

the two-class method of income per share.

In order to determine the net income (loss) attributable to both the redeemable shares and

non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable

shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid.

The Company then

allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and

non-redeemable shares.

Any remeasurement of the accretion to redemption value of the shares subject to possible redemption was considered

to be dividends paid to the public shareholders.

For the three months ended March 31, 2026 and 2025, the Company did not have any dilutive

securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of

June 30, 2026

Earnings (Loss) Per Ordinary Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”.

The unaudited condensed consolidated statements of operations and comprehensive income include a presentation of earnings (loss) per redeemable share and earnings (loss) per non-redeemable share following the two-class method of income per share.

In order to determine the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using the total net income (loss) less any dividends paid.

The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between the redeemable and non-redeemable shares.

Any remeasurement of the accretion to redemption value of the shares subject to possible redemption was considered to be dividends paid to the public shareholders.

For the three and six months ended June 30, 2026 and 2025, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company.

As a result, diluted income (loss) per share is the same as basic income (loss) per share for the period presented.

Net income (loss) used in the calculation of earnings

(loss) per share is as the following:

Net income used in the calculation of earnings (loss) per share is as the following:

Schedule of consolidated statements of operations

Three Months Ended

Six Months Ended

Accretion of redeemable ordinary shares to redemption value

Net loss including accretion of redeemable ordinary shares to redemption value

Earnings (loss) per share

presented on the unaudited condensed consolidated statement of operations and comprehensive income is based on the following:

Earnings (loss) per share presented on the unaudited condensed consolidated statement of operations and comprehensive income for the three months ended June 30, 2026 and 2025 is based on the following:

Schedule of Basic and Diluted Net Loss Per Share

For the Three Months Ended March 31,

For the Three Months Ended June 30,

Ordinary Share

12 unchanged sentences

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

June 30, 2026

Earnings (loss) per share presented on the unaudited condensed consolidated statement of operations and comprehensive income for the six months ended June 30, 2026 and 2025 is based on the following:

For the Six Months Ended June 30,

Ordinary Share

Non-Redeemable

Ordinary Share

Non-Redeemable

Ordinary Share

Allocation of net loss

Accretion of redeemable ordinary shares to redemption value

Allocation of net income (loss)

Denominators:

Weighted-average ordinary shares outstanding

Basic and diluted earnings (loss) per share

The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”).

4 unchanged sentences

ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

The Company recognizes accrued interest and

penalties related to unrecognized tax benefits as income tax expense.

There were no

unrecognized tax benefits and no

amounts accrued for interest and penalties as of March 31, 2026 and December 31, 2025.

The Company is currently not aware of

any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense.

There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2026 and December 31, 2025.

The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

The Company determined that the Cayman Islands is the Company ’ s only major tax jurisdiction.

2 unchanged sentences

The Company ’ s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

There is currently no taxation imposed on income

by the Government of the Cayman Islands for the three months ended March 31, 2026 and 2025.

There is currently no taxation imposed on income by the Government of the Cayman Islands for the three and six months ended June 30, 2026 and 2025.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2026

Recent Accounting Pronouncements

In November 2024, the FASB issued ASU 2024-03,

Income Statement — Reporting Comprehensive Income —

Expense Disaggregation Disclosures (Subtopic 220-40):

Disaggregation of Income Statement Expenses ( “ ASU

2024-03 ” ) which requires detailed disclosures in the notes to financial statements disaggregating

specific expense categories and certain other disclosures to provide enhanced transparency into the nature and function of expenses.

FASB further clarified the effective date in January 2025 with the issuance of ASU 2025-01, Income Statement —

Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40):

In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40):

Disaggregation of Income Statement Expenses ( “ ASU 2024-03 ” ) which requires detailed disclosures in the notes to financial statements disaggregating specific expense categories and certain other disclosures to provide enhanced transparency into the nature and function of expenses.

The FASB further clarified the effective date in January 2025 with the issuance of ASU 2025-01, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40):

Clarifying the Effective Date ( “ ASU 2025-01 ” ).

ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning

after December 15, 2027, with early adoption permitted.

The requirements should be applied on a prospective basis while retrospective

application is permitted.

The Company does not expect to adopt this guidance early and does not expect the adoption of this ASU to have

a material impact on its condensed consolidated financial statements.

On December 8, 2025, the FASB issued ASU 2025-11

— Interim Reporting ( “ ASU 2025-11 ” )

which is intended to improve the navigability of the guidance in ASC 270, Interim Reporting, and clarify when it applies.

Under the amendments,

an entity is subject to ASC 270 if it provides interim financial statements and notes in accordance with GAAP.

ASU 2025-11 also addresses

the form and content of such financial statements, interim disclosures requirements, and establishes a principle under which an entity

must disclose events since the end of the last annual reporting period that have a material impact on the entity.

ASU 2025-11 is effective

for interim reporting periods within annual reporting periods beginning after December 15, 2027, and early adoption is permitted.

Company is currently evaluating the impact the adoption of ASU 2025-11 may have on its condensed consolidated financial statements.

ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted.

The requirements should be applied on a prospective basis while retrospective application is permitted.

The Company does not expect to adopt this guidance early and does not expect the adoption of this ASU to have a material impact on its condensed consolidated financial statements.

On December 8, 2025, the FASB issued ASU 2025-11 — Interim Reporting ( “ ASU 2025-11 ” ) which is intended to improve the navigability of the guidance in ASC 270, Interim Reporting, and clarify when it applies.

Under the amendments, an entity is subject to ASC 270 if it provides interim financial statements and notes in accordance with GAAP.

ASU 2025-11 also addresses the form and content of such financial statements, interim disclosures requirements, and establishes a principle under which an entity must disclose events since the end of the last annual reporting period that have a material impact on the entity.

ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, and early adoption is permitted.

The Company is currently evaluating the impact the adoption of ASU 2025-11 may have on its condensed consolidated financial statements.

Management does not believe that any recently issued, but not effective, accounting pronouncements, if currently adopted, would have a material effect on the Company ’ s financial statements.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

Note 3 — Initial Public Offering

6 unchanged sentences

All of the 5,750,000 public shares sold as part of the Public Units in the IPO contain a redemption feature and the Company has classified related proceeds in temporary equity as disclosed in Note 2.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2026

Note 4 — Private Placement

6 unchanged sentences

Nature of relationship with the related party:

The following is a list of the related party,

with which the Company has transactions:

The following is a list of the related party, with which the Company has transactions:

Name of Related Parties

5 unchanged sentences

On September 13, 2024, the over-allotment option was exercised and none of the Founder Shares were subject to forfeiture.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

The Sponsor has agreed not to transfer, assign or sell their Founder Shares (excluding any units or shares comprising the units acquired in the offering) until the earlier to occur of (a) twelve months after the completion of the Company’s initial Business Combination and (b) upon completion of the Company’s initial Business Combination, (x) if the last reported sale price of the Company’s ordinary shares equals or exceeds $12.00 per unit (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after the Company’s initial Business Combination that results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.

6 unchanged sentences

Shortly after completion of the IPO, such amount was fully repaid.

(iii) Promissory Note — Related Party

On March 4, 2026, the Company’s Board of

Directors approved the First Extension, extending the deadline to consummate a Business Combination from March 13, 2026 to April 13, 2026.

On March 9, 2026, in connection with the First Extension, the Company issued an unsecured promissory note (the “First Extension

Promissory Note”) to the Sponsor in the principal amount of $ 191,475 .

The First Extension Promissory Note bears no interest and

is payable on the earlier of:

(i) the consummation of the Company’s initial Business Combination, or (ii) the date the Company is

wound up and liquidates.

If the Company fails to consummate a Business Combination by the expiration of its prescribed timeframe and liquidates,

the First Extension Promissory Note will be forgiven and the Sponsor will have no right to payment.

At the Sponsor’s option, prior to full repayment,

all or any portion of the unpaid principal may be converted into units of the Company at $10.00 per unit upon consummation of a Business

The conversion units are identical to the Placement Units issued to the Sponsor in the private placement concurrent with

the Company’s IPO.

The Sponsor’s conversion right, when aggregated with other similar working capital or extension loans,

shall not exceed $ 1,500,000 in aggregate principal.

The Sponsor has waived any claim to or from the

Trust Account and agreed not to seek recourse against the Trust Account for any reason.

An event of default occurs if the Company fails

to pay within five business days of the due date or commences voluntary bankruptcy proceedings.

The proceeds of the First Extension Promissory

Note of $ 191,475 were deposited directly into the Company’s Trust Account to fund the First Extension on March 11, 2026.

(iv) Working Capital Loans

In addition, in order to finance transaction costs

in connection with an intended initial Business Combination, the Sponsor, the Company’s officers and directors may, but are not

obligated to, loan the Company funds as may be required.

If the Company completes the initial Business Combination, it intends to repay

such loaned amount at closing.

In the event that the initial Business Combination does not close, the Company may use a portion of the

working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for

such repayment.

Up to $ 1,500,000

of such working capital loans (“Working Capital Loans”) made by the Sponsor, the Company’s officers and directors,

or the Company’s or their affiliates to the Company prior to or in connection with its initial Business Combination may be convertible

into units, at a price of $10.00 per unit at the option of the lender, upon consummation of its initial Business Combination.

would be identical to the Placement Units.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

For the three months ended March 31, 2026 and

2025, the Company had no

borrowings under the Working Capital Loans.

June 30, 2026

(iii) Promissory Note — Related Party (Extension)

On March 4, 2026, April 7, 2026, May 7, 2026, June 7, 2026 and July 7, 2026, the Company’s Board of Directors approved the First, Second, Third, Fourth and Fifth Extensions, respectively, extending the deadline to consummate a Business Combination from March 13, 2026 to April 13, 2026, from April 13, 2026 to May 13, 2026, from May 13, 2026 to June 13, 2026, from June 13, 2026 to July 13, 2026, and from July 13, 2026 to August 13, 2026, respectively.

On March 9, 2026, April 11, 2026, May 11, 2026, June 11, 2026 and July 13, 2026, in connection with each Extension, the Company issued an unsecured promissory note to the Sponsor in the principal amount of $ 191,475 each (collectively the “Extension Promissory Notes”).

The Extension Promissory Notes bear no interest and are payable on the earlier of:

(i) the consummation of the Company’s initial Business Combination, or (ii) the date the Company is wound up and liquidates.

If the Company fails to consummate a Business Combination by the expiration of its prescribed timeframe and liquidates, the Extension Promissory Notes will be forgiven and the Sponsor will have no right to payment.

At the Sponsor’s option, prior to full repayment, all or any portion of the unpaid principal may be converted into units of the Company at $10.00 per unit upon consummation of a Business Combination.

The conversion units are identical to the Placement Units issued to the Sponsor in the private placement concurrent with the Company’s IPO.

The Sponsor’s conversion right, when aggregated with other similar working capital or extension loans, shall not exceed $ 1,500,000 in aggregate principal.

The Sponsor has waived any claim to or from the Trust Account and agreed not to seek recourse against the Trust Account for any reason.

An event of default occurs if the Company fails to pay within five business days of the due date or commences voluntary bankruptcy proceedings.

As of June 30, 2026, the proceeds of the Extension Promissory Notes of $ 191,475 each (aggregating $765,900 in total) were deposited directly into the Company’s Trust Account to fund the corresponding Extensions.

(iv) Working Capital Loans

In addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor, the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required.

If the Company completes the initial Business Combination, it intends to repay such loaned amount at closing.

In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used for such repayment.

Up to $ 1,500,000 of such working capital loans (“Working Capital Loans”) made by the Sponsor, the Company’s officers and directors, or the Company’s or their affiliates to the Company prior to or in connection with its initial Business Combination may be convertible into units, at a price of $10.00 per unit at the option of the lender, upon consummation of its initial Business Combination.

The units would be identical to the Placement Units.

For the three and six months ended June 30, 2026 and 2025, the Company had no borrowings under the Working Capital Loans.

(v) Administrative Services Arrangement

1 unchanged sentence

Upon completion of its initial Business Combination or its liquidation, the Company will cease paying these monthly fees.

For the three months ended March 31, 2026

and 2025, the Company has accrued $ 30,000

for the service provided by the Sponsor, respectively.

For the three months ended June 30, 2026 and 2025, the Company has accrued $ 30,333 and $ 30,333 for the service provided by the Sponsor, respectively.

For the six months ended June 30, 2026 and 2025, the Company has accrued $ 60,333 and $ 60,333 for the service provided by the Sponsor, respectively.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2026

Balance with the related party:

6 unchanged sentences

Promissory note for extension

The amount due to the related party is non-interest bearing and due

The amount due to the related party is non-interest bearing and due on demand.

Note 6 — Shareholder’s Equity

Ordinary Shares

The Company is authorized to issue 500,000,000

ordinary shares with a par value of $ 0.0001

On January 30, 2024, the Company issued 10,000

ordinary shares to the Sponsor for an aggregate purchase price of $ 1 .

On February 27, 2024, the Company issued 1,437,500

ordinary shares to the Sponsor including an aggregate of 187,500

shares that are subject to forfeiture to the extent that the underwriter’s over-allotment option is not exercised in full or

in part, so that the initial shareholder will own 20% of the Company’s issued and outstanding ordinary shares (excluding the

Private Placement shares and Representative shares (as described below) and assuming the initial shareholder does not purchase any

shares in the IPO).

Meanwhile, the Sponsor irrevocably surrendered to the Company for cancellation and for nil consideration 10,000

ordinary shares.

The Company is authorized to issue 500,000,000 ordinary shares with a par value of $ 0.0001 per share.

On January 30, 2024, the Company issued 10,000 ordinary shares to the Sponsor for an aggregate purchase price of $ 1 .

On February 27, 2024, the Company issued 1,437,500 ordinary shares to the Sponsor including an aggregate of 187,500 shares that are subject to forfeiture to the extent that the underwriter’s over-allotment option is not exercised in full or in part, so that the initial shareholder will own 20% of the Company’s issued and outstanding ordinary shares (excluding the Private Placement shares and Representative shares (as described below) and assuming the initial shareholder does not purchase any shares in the IPO).

Meanwhile, the Sponsor irrevocably surrendered to the Company for cancellation and for nil consideration 10,000 ordinary shares.

On September 13, 2024, the Company consummated its IPO of 5,000,000 units at $10.00 per Unit, with the exercise of the underwriter’s over-allotment option of 750,000 units, generating gross proceeds of $ 57,500,000 .

1 unchanged sentence

Simultaneously with the consummation of the closing of the IPO, the Company issued 299,000 ordinary shares to the Sponsor in the private placement.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

On September 13, 2024, the Company issued 57,500 Representative Shares to the representative of the underwriters (and/or its designees) as part of the underwriting compensation.

1 unchanged sentence

Pursuant to FINRA Rule 5110I(1), these securities will not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the commencement of sales in this offering, nor may they be sold, transferred, assigned, pledged or hypothecated for a period of 180 days immediately following September 13, 2024 except to any underwriter and selected dealer participating in the offering and their officers, partners, registered persons or affiliates.

As of March 31, 2026 and December 31, 2025,

as a result of closing of the IPO, the exercise of the Representative’s Over-Allotment Option and the sales of Placement Units

in the private placement, there were 7,544,000

ordinary shares issued and outstanding, including 5,750,000

ordinary shares subject to possible redemption, which are classified as temporary equity, and 1,794,000 ordinary shares.

ordinary shares issued and outstanding, consisting of 1,437,500 ordinary shares of founder shares, 299,000 ordinary shares from

private placement and 57,500 ordinary shares to the underwriter.

As of March 31, 2026 and December 31, 2025, there were 5,750,000 public rights included in the Public Units and 299,000 private rights include in the Placement Units outstanding.

As of June 30, 2026 and December 31, 2025, as a result of closing of the IPO, the exercise of the Representative’s Over-Allotment Option and the sales of Placement Units in the private placement, there were 7,544,000 ordinary shares issued and outstanding, including 5,750,000 ordinary shares subject to possible redemption, which are classified as temporary equity, and 1,794,000 ordinary shares.

1,794,000 ordinary shares issued and outstanding, consisting of 1,437,500 ordinary shares of founder shares, 299,000 ordinary shares from private placement and 57,500 ordinary shares to the underwriter.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2026

As of June 30, 2026 and December 31, 2025, there were 5,750,000 public rights included in the Public Units and 299,000 private rights include in the Placement Units outstanding.

There was no right attached to the Representative Shares.

7 unchanged sentences

Accordingly, the Rights may expire worthless.

Note 7 — Commitments &Contingencies

7 — Commitments & Contingencies

Registration Rights

The holders of the Founder Shares, Private

Placement Units (and their underlying securities), and any Working Capital Loans (up to $ 1,500,000 ) are entitled to registration

rights pursuant to the registration rights agreement signed on the effective date of the IPO, requiring the Company to register such

securities for resale.

The holders of these securities are entitled to make up to three demands, excluding short form demands, that

the Company registers such securities.

In addition, the holders have certain “piggy-back” registration rights with

respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the

Company to register for resale such securities pursuant to Rule 415 under the Securities Act.

The Company will bear the

expenses incurred in connection with the filing of any such registration statements.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

The holders of the Founder Shares, Private Placement Units (and their underlying securities), and any Working Capital Loans (up to $ 1,500,000 ) are entitled to registration rights pursuant to the registration rights agreement signed on the effective date of the IPO, requiring the Company to register such securities for resale.

The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities.

In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act.

The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

2 unchanged sentences

The underwriters were entitled to an underwriting discount of 4.0% of the gross proceeds of the IPO, of which (i) 1.5% of the gross proceeds of the IPO, or $ 862,500 , were paid in cash at the closing of the IPO, (ii) 57,500 ordinary shares were paid at the closing of the IPO as representative shares (“Representative Shares”) (such representative shares shall be registered so as to circumvent reliance on the Rule 144 exemption and shall only therein be subject to FINRA’s 180-day lock-up period rule), (iii) 1.0% of the gross proceeds of the IPO, or 575,000 , will be paid in cash, and 28,750 representative shares will be issued, both of which as the deferred underwriting commission at the consummation of a Business Combination.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2026

Note 8 — Segment Information

3 unchanged sentences

Accordingly, management has determined that there is only one reportable segment.

The CODM assesses performance for the single segment

and decides on resource allocation based on the net income or loss reported on the condensed consolidated statements of operations and

comprehensive income.

The CODM assesses performance for the single segment and decides on resource allocation based on the net income or loss reported on the condensed consolidated statements of operations and comprehensive income.

The measure of segment assets is reported on the condensed consolidated balance sheet as total assets.

When evaluating

the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included

in net income or loss and total assets, which include the following:

When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in net income or loss and total assets, which include the following:

Schedule of Segment Information

1 unchanged sentence

Three Months Ended

Six Months Ended

Operating expenses

Income earned on marketable securities held in Trust Account

The CODM reviews income earned on marketable securities held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.

Operating expenses are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Business Combination period.

The CODM also reviews operating expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.

Operating expenses, as reported on the condensed consolidated statements of operations and comprehensive income, are the significant segment expenses provided to the CODM on a regular basis.

FUTURE VISION II ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2026

Operating expenses are reviewed and monitored

by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction

within the Business Combination period.

The CODM also reviews operating expenses to manage, maintain and enforce all contractual agreements

to ensure costs are aligned with all agreements and budget.

Operating expenses, as reported on the condensed consolidated statements of

operations and comprehensive income, are the significant segment expenses provided to the CODM on a regular basis.

June 30, 2026

Note 9 — Subsequent Events

The Company evaluated subsequent events and transactions

that occurred after the consolidated balance sheet date through the date of these unaudited condensed consolidated financial statements

Except as disclosed, the Company did not identify any other subsequent events that would require adjustment or disclosure

in the condensed consolidated financial statements.

On April 8, 2026, in connection with the second one-month

extension of the deadline to consummate a business combination from April 13, 2026 to May 13, 2026 (the “Second Extension”),

the Company issued an unsecured promissory note (the “Second Extension Promissory Note”) to the Sponsor in the principal

amount of $ 191,475 .

The terms of the Second Extension Promissory Note are substantially identical in all material respects to the terms of the First Extension

Promissory Note, including with respect to interest, maturity, forgiveness upon liquidation, conversion rights, and waiver of claims

against the Trust Account.

The proceeds of the Second Extension Promissory Note were deposited into the Company’s Trust Account

to fund the Second Extension.

On May 8, 2026, in connection with the third one-month extension of the deadline to consummate a business

combination from May 13, 2026 to June 13, 2026 (the “Third Extension”), the Company issued an unsecured promissory note (the

“Third Extension Promissory Note”) to the Sponsor in the principal amount of $ 191,475 .

The terms of the Third Extension Promissory

Note are substantially identical in all material respects to the terms of the First and Second Extension Promissory Note, including with

respect to interest, maturity, forgiveness upon liquidation, conversion rights, and waiver of claims against the Trust Account.

of the Third Extension Promissory Note were deposited into the Company’s Trust Account to fund the Third Extension.

The Company evaluated subsequent events and transactions that occurred after the consolidated balance sheet date through the date of these unaudited condensed consolidated financial statements were issued.

Except as disclosed, the Company did not identify any other subsequent events that would require adjustment or disclosure in the condensed consolidated financial statements.

On July 8, 2026, in connection with the fifth one-month extension of the deadline to consummate a business combination from July 13, 2026 to August 13, 2026 (the “Fifth Extension”), the Company issued an unsecured promissory note (the “Fifth Extension Promissory Note”) to the Sponsor in the principal amount of $ 191,475 .

The terms of the Fifth Extension Promissory Note are substantially identical in all material respects to the terms of each of the Extension Promissory Notes, including with respect to interest, maturity, forgiveness upon liquidation, conversion rights, and waiver of claims against the Trust Account.

The proceeds of the Fifth Extension Promissory Note were deposited into the Company’s Trust Account to fund the Fifth Extension.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1. Financial Statements